Characteristics of modern Gleason 9/10 prostate adenocarcinoma: a single tertiary centre experience within the Republic of Ireland

被引:0
作者
F. O’Kelly
S. Elamin
A. Cahill
P. Aherne
J. White
J. Buckley
K. N. O’Regan
A. Brady
D. G. Power
M. F. O’Brien
P. Sweeney
N. Mayer
P. J. Kelly
机构
[1] Cork/Mercy University Hospitals,Department of Urology
[2] Cork/Mercy University Hospitals,Department of Radiology
[3] Cork/Mercy University Hospitals,Department of Pathology
[4] Cork/Mercy University Hospitals,Department of Medical Oncology
[5] Cork/Mercy University Hospitals,Department of Radiation Oncology
来源
World Journal of Urology | 2014年 / 32卷
关键词
Prostate cancer; Gleason grade; Perineural invasion; Family history; Staging; TRUS biopsy; Radiation therapy; Radical prostatectomy; Biochemical recurrence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1067 / 1074
页数:7
相关论文
共 85 条
[21]  
Fajardo DA(2010)Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the shared equal access regional cancer hospital database BJU Int 105 28-661
[22]  
Gonzalez-Roibon N(2013)Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy Urology 81 826-1327
[23]  
Eifler JB(2012)Prostate cancer risk assessment model: a scoring model based on the Swedish family-cancer database J Med Genet 49 345-2147
[24]  
Feng Z(2012)Concordance of tumour differentiation among brothers with prostate cancer Eur Urol 62 656-494
[25]  
Lin BM(2010)Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study J Urol 184 1322-377
[26]  
Epstein JI(2011)Delay of surgery in men with low risk prostate cancer J Urol 185 2143-undefined
[27]  
Allsbrook WC(1999)Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients Urology 54 490-undefined
[28]  
Amin MB(2008)The role of endorectal coil MRI in preoperative staging and decision-making for the treatment of clinically localized prostate cancer MAGMA 21 371-undefined
[29]  
Uemura H(undefined)undefined undefined undefined undefined-undefined
[30]  
Hoshino K(undefined)undefined undefined undefined undefined-undefined